Updates are available Correction dated 2022-08-12

Article History

Received: 29 June 2021

Revised: 10 October 2021

Accepted: 2 November 2021

First Online: 20 November 2021

Change Date: 12 August 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00415-022-11290-w

Declarations

:

: Financial: Sophie Lehnerer and Sarah Hoffmann have received speaker’s honoraria and honoraria for attendance at advisory boards from Alexion. Maike Krause received speaker’s honoraria from Argnx. Frauke Stascheit received speaker’s honoraria from Alexion. Andreas Meisel received speaker’s honoraria from Alexion, Grifols and Hormosan. He received honoraria from Alexion, UCB, MorphoSys and Argnx for consulting services and financial research support from Octapharma and Alexion. All other authors report no disclosures relevant to the manuscript. Non-financial: Andreas Meisel is Chairman of the medical advisory board of the German Myasthenia Gravis Society.

: The study was conducted in accordance to the declaration of Helsinki and received ethics approval by the institutional ethics committee of Charité University Medicine Berlin (EA1/008/19). The study was conducted in accordance to the declaration of Helsinki and the STROBE reporting guidelines and was registered on clinicaltrials.gov (NCT03205306).

: Data were obtained by a large questionnaire-based survey. No written informed consent was obtained from the study participants because the data collection was completely anonymous.

: All authors have approved the manuscript for submission, accordingly the manuscript conforms to the journal’s policies. The authors take full responsibility for the data, the analyses and interpretation, and the conduct of the research. They have full access to all of the data, and the right to publish any and all data separate and apart from the guidance of any sponsor.